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Introduction:	  
  Hematopoietic stem cells (HSCs) represent a unique cell population capable of self-renewal 
and multi-lineage differentiation thereby achieving the lifelong sustainment of hematopoiesis. 
HSC transplantation has proven to be beneficial for treating various diseases so it is therefore 
important to elucidate the molecular determinants leading to successful HSC engraftment. 
Hematopoietic reconstitution is the dynamic process following transplantation and can be 
divided into three major steps:  1) a homing/lodging steps where HSCs transmigrated into the 
cavity of bone marrow (BM);  2) a BM repopulation steps where HSCs replicated themselves 
while producing progenitor cells with multi-lineage differentiation potential;  3) a peripheral 
reconstitution steps where mature cells are released from BM to periphery (Fig1).  Failure in 
any of these processes could impair transplantation outcomes. 
  Signaling through the C-X-C chemokine receptor type 4 (CXCR4) has been implicated in 
HSC engraftment from the observation that transplantation of mouse BM cells lacking this 
receptor results in poor hematopoietic reconstitution.  In contrast, overexpression of CXCR4 
receptor in human hematopoietic stem and progenitor cells (HSPCs) led to the enhanced 
engraftment in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice, 
suggesting the modification of this signaling in donor cells may benefit the transplanted patient. 
However, it remains unclear which steps specifically is CXCR4 attributable to and subsequently 
how it influences the fate of purified transplanted donor HSCs.  In this study, we aim to 
investigate the roles of CXCR4 in HSC repopulation kinetics in vivo by using both 
gain-of-function (overexpression) and loss-of-function (knockout or desensitization) strategies. 
In semi-quantitative analysis of gain-of-function effects, we use not only wild-type (WT) 
Cxcr4-overexpressing cells but also cells expressing Cxcr4 with a specific C-terminal deletion 
(ΔC) homologous to that found in patient with disorder termed warts, hypogammaglobulinemia, 
infections, and myelokathexis (WHIM) syndrome.  This mutation is regarded as 
gain-of-function mutation because it increases the cell-surface stability of CXCR4 receptor 
without impairing CXCR4 signaling capabilities.  By using this approach, we assessed each of 
the multiple steps in donor cell reconstitution in mice the received Cxcr4-modified HSC/HSPCs 
and dissected the stage-specific roles that Cxcr4 signaling plays in transplanted cells.   
 
Materials and methods:  
  In this study HSCs were defined as CD34neg/low c-Kit+ Sca-1+ Lineage marker-negative. As a 
loss-of-function study, CXCR4 was conditionally deleted in HSCs (CXCR4-KO HSCs) by the 
Mx1-Cre-loxP system before transplantation.  As a gain-of-function study, we generated HSC 
populations overexpressing either wild-type (WT)- or C-terminal truncated (ΔC)-CXCR4 by 
retroviral gene transfer.  Control HSCs were those transduced with the mock virus in 
gain-of-function studies or from littermate control in loss-of function experiments.   
  Biological characteristics of those Cxcr4-modified HSCs were assessed in vitro with assays 
testing receptor internalization, chemotaxis, proliferation, colony formation, and 
cobblestone-area forming ability.  The later is an indication of cells with long-term 
repopulating potential.  In vivo, the homing/lodging phases (<1wk) were examined by plating 
recipient bone marrow cells onto methylcellulose or counting by flow cytometry.  To assess 
short-term (2-3 weeks) and long-term (>16 weeks) reconstitution ability in test cells, a 
competitive repopulation assay was utilized.  By looking at the chimerism of donor cells in the 
BM or peripheral blood (PB) of recipient mice at specific time points, we assessed how Cxcr4 
signaling in the transplanted cells would contribute to the each component in hematopoietic 
reconstitution process.  
 
Results:   
  In vitro studies:  Stepwise gain-of-function effect of exogenous Cxcr4 on transduced HSCs, 
with greater response for ΔC-Cxcr4 was observed in chemotaxis and proliferation assay. 
Cobblestone-area forming ability was greater in HSCs overexpressing ΔC-Cxcr4 than the Mock 
control and was detracted from Cxcr4-KO HSCs.  Collectively, these data suggesting that 
augmented Cxcr4 signaling favor the survival and proliferation of HSCs in vitro.  
  In vivo studies:  1) The homing/lodging steps.  It did not appear that there were any 
significant differences through the modification of Cxcr4 expression in the number of colony 
forming cells detectable in recipient BM within this phase (as earliest, 16 hours), indicating that 
this signaling is dispensable in donor HSC homing.  2) The BM repopulation steps. 
Impairment of hematopoietic repopulation in BM became evident for Cxcr4-KO HSCs between 
2-3 wks.  On the other hand, stepwise enhancement in donor chimerism was visible in the BM 
with ΔC-Cxcr4 cells, suggesting the advantage in the BM repopulation of Cxcr4-augmented 
HSCs.  This advantage was also noticeable in the BM cells throughout developmental stages 
of HSCs expressing gain-of-function Cxcr4 receptor in long-term recipients (>16 weeks).  
More importantly, donor chimerism in long-term HSCs (LT-HSCs) population was also 
increased in Cxcr4-augmented group, which suggested that Cxcr4-signaling dependent donor 
cell expansion may occur at a stem cell level.  Even though these “phenotypically-defined” 
LT-HSCs might not necessarily imply that functional HSC numbers were amplified.  3) The 
peripheral reconstitution steps.  Cxcr4-KO HSCs showed poor hematopoietic reconstitution 
potentials which interestingly, was an observation also made with donor HSCs overexpressing 
WT- or ΔC-Cxcr4.  Systemic injection of the Cxcr4 antagonist AMD3100 into long-term 
recipient increased PB donor chimerism significantly in WT- and ΔC-Cxcr4 groups, suggesting 
that blunted peripheral mobilization of donor cells played a causal role in poor PB reconstitution 
in these mice. 
  Mechanistic analysis revealed that altered phosphorylation kinetics of ERK and/or varied 
expression profile of adhesion molecules in the Cxcr4 overexpressing cells may constitute the 
basis for the observed positive effects.  
 
Conclusions:  
  We have addressed stage-specific roles for Cxcr4 signaling in donor cell repopulation in BM for 
the first time using purified mouse HSC/HSPCs.  With unique combinational approaches that 
utilized both loss-of-function and gain-of-function modification of Cxcr4 receptors, we found that 
Cxcr4 signaling appears unimportant for the homing/lodging of mouse HSC/HSPCs, but vital for 
their subsequent repopulation of BM.  Cxcr4 signal enhancement likely favored BM repopulation 
by donor cells at a level of primitive cell populations, but was shown to be detrimental to PB 
reconstitution when sustained too long.  Consequently, we think it important to investigate further 
when and how long signaling via this chemokine receptor is to be modified in order favorably to 
enhance HSPC engraftment in future transplantation medicine. 
 
 
 
 
 
 
 
 
 
 
Figure 1. The dynamic process of hematopoietic reconstitution after transplantation. 
 
 
 
 
 
 
 
 
 
 
The stage-specific roles for Cxcr4 signaling in transplanted donor cells. 
